首页> 外文期刊>BMJ Open >Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol
【24h】

Validity of breast, lung and colorectal cancer diagnoses in administrative databases: a systematic review protocol

机译:在行政数据库中对乳腺癌,肺癌和大肠癌的诊断有效性:系统的审查方案

获取原文
       

摘要

Introduction Breast, lung and colorectal cancers constitute the most common cancers worldwide and their epidemiology, related health outcomes and quality indicators can be studied using administrative healthcare databases. To constitute a reliable source for research, administrative healthcare databases need to be validated. The aim of this protocol is to perform the first systematic review of studies reporting the validation of International Classification of Diseases 9th and 10th revision codes to identify breast, lung and colorectal cancer diagnoses in administrative healthcare databases. Methods and analysis This review protocol has been developed according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol (PRISMA-P) 2015 statement. We will search the following databases: MEDLINE, EMBASE, Web of Science and the Cochrane Library, using appropriate search strategies. We will include validation studies that used administrative data to identify breast, lung and colorectal cancer diagnoses or studies that evaluated the validity of breast, lung and colorectal cancer codes in administrative data. The following inclusion criteria will be used: (1) the presence of a reference standard case definition for the disease of interest; (2) the presence of at least one test measure (eg, sensitivity, positive predictive values, etc) and (3) the use of data source from an administrative database. Pairs of reviewers will independently abstract data using standardised forms and will assess quality using a checklist based on the Standards for Reporting of Diagnostic accuracy (STARD) criteria. Ethics and dissemination Ethics approval is not required. We will submit results of this study to a peer-reviewed journal for publication. The results will serve as a guide to identify appropriate case definitions and algorithms of breast, lung and colorectal cancers for researchers involved in validating administrative healthcare databases as well as for outcome research on these conditions that used administrative healthcare databases. Trial registration number CRD42015026881.
机译:简介乳腺癌,肺癌和大肠癌是全球最常见的癌症,可以使用行政医疗数据库来研究其流行病学,相关的健康结果和质量指标。为了构成可靠的研究来源,需要验证行政医疗数据库。该协议的目的是对报告的国际疾病分类第9版和第10版修订代码进行验证,以对管理性医疗数据库中的乳腺癌,肺癌和结直肠癌进行诊断,以进行研究的首次系统评价。方法和分析该审查方案是根据2015年系统评价和元分析方案的首选报告项目(PRISMA-P)声明制定的。我们将使用适当的搜索策略搜索以下数据库:MEDLINE,EMBASE,Web of Science和Cochrane库。我们将包括使用行政数据确定乳腺癌,肺癌和大肠癌诊断的验证研究,或评估行政数据中评估乳腺癌,肺癌和大肠癌代码有效性的研究。将使用以下纳入标准:(1)是否存在针对所关注疾病的参考标准病例定义; (2)是否存在至少一种测试手段(例如,敏感性,阳性预测值等),以及(3)使用来自管理数据库的数据源。成对的审阅者将使用标准化表格独立地提取数据,并将根据诊断准确性报告标准(STARD)的标准使用清单对质量进行评估。道德与传播不需要道德批准。我们将把这项研究的结果提交到同行评审的期刊上发表。该结果将为确定验证行政医疗保健数据库的研究人员以及使用行政医疗保健数据库的这些状况的结局研究提供指导,为乳腺癌,肺癌和大肠癌确定合适的病例定义和算法。试用注册号CRD42015026881。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号